Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 10/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5598322 | 1.00 | CYP1A2 (0.54) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL8518471 | 1.00 | CYP1A2 (0.54) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL9576975 | 1.00 | CYP1A2 (0.54) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL19283429 | 1.00 | CYP1A2 (0.54) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL13058166 | 1.00 | CYP1A2 (0.54) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL2272354 | 0.98 | CYP1A2 (0.51) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL29065659 | 0.93 | CYP1A2 (0.49) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL2344886 | 0.92 | CYP1A2 (0.44) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL14539537 | 0.92 | CYP1A2 (0.44) | CYP1A2ALDH1A1PPARGEPHX1GRM2 | |
| SCHEMBL17227787 | 0.90 | CYP1A2 (0.40) | CYP1A2ALDH1A1PPARGEPHX1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150329666-A1 | HYDROCARBON POLYMERS COMPRISING A 2-OXO-1,3-DIOXOLAN-4-YL END GROUP, PREPARATION AND USE THEREOF | BOSTIK SA (FR) | 2015-11-19 | — | — | US | disclosed |